Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Curis, Inc. (CRIS)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CRIS
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
6 Microcaps that May Reward You
Dec 28, 2009
•
Microcap Speculator
•
6 Comments
Lihir Gold: A Stellar Options Trade
Dec 3, 2009
•
Marco Hickey
•
Comment!
Small Cap Stocks Battling Brain Cancer
Sep 7, 2009
•
Mike Havrilla
•
4 Comments
Curis' Cancer Therapy Arouses Curiosity
Sep 6, 2009
•
Kris Tuttle
•
1 Comment
Breakout Stocks to Watch This Week
Sep 1, 2009
•
Marco Hickey
•
3 Comments
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
Jul 1, 2009
•
M. E. Garza
•
Comment!
Spicing Up the Biotech Portfolio with Microcaps CuraGen and Curis
Feb 23, 2009
•
Ohad Hammer
•
Comment!
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
7 Comments
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
3 Comments
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
3 Comments
Biotech Day in Review: Critical Therapeutics Climbs on Co-Promotion Deal
Mar 15, 2007
•
Centient Biotech Investor
•
Comment!
Investing in Stem Cell Stocks: Growth Industry of the Future?
Feb 21, 2007
•
Stockerblog
•
12 Comments
Biotech Day In Review: AstraZeneca Enters Two Partnerships Worth $800 Million
Feb 1, 2007
•
Centient Biotech Investor
•
Comment!